4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
Phase 1/2 dose-escalation and randomized, controlled, masked expansion trial in adults with wet AMD undergoing active anti-VEGF treatment
Epistemonikos ID: 07fbd0eeaeb69bc028d3b7ce8867f6013a5f6c88
First added on: May 10, 2024